These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
480 related items for PubMed ID: 8107283
1. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC]. Okajima K. Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283 [Abstract] [Full Text] [Related]
2. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)]. Nakagawa T, Saito H, Watanabe Y, Sato M, Murakawa E. Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842 [Abstract] [Full Text] [Related]
3. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T. Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [Abstract] [Full Text] [Related]
4. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome. Egbring R, Seitz R, Blanke H, Leititis J, Kesper HJ, Burghard R, Fuchs G, Lerch L. Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425 [Abstract] [Full Text] [Related]
5. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation]. Fukuda C, Iijima K, Nakamura K. Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061 [Abstract] [Full Text] [Related]
6. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation. Takahashi H, Tatewaki W, Wada K, Niwano H, Shibata A. Thromb Haemost; 1990 Jun 28; 63(3):340-4. PubMed ID: 2402738 [Abstract] [Full Text] [Related]
7. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon]. Ohsato K, Okamoto K. Nihon Rinsho; 1993 Jan 28; 51(1):50-5. PubMed ID: 8381885 [Abstract] [Full Text] [Related]
8. [Clinical application of laboratory diagnosis: leukemia and DIC]. Deguchi K, Zhao LJ, Shirakawa S. Rinsho Byori; 1991 Jul 28; 39(7):736-42. PubMed ID: 1833571 [Abstract] [Full Text] [Related]
9. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation. Gando S, Hayakawa M, Sawamura A, Hoshino H, Oshiro A, Kubota N, Jesmin S. Thromb Res; 2007 Jul 28; 121(1):67-73. PubMed ID: 17397908 [Abstract] [Full Text] [Related]
10. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)]. Koga S. Rinsho Byori; 2004 Apr 28; 52(4):355-61. PubMed ID: 15164605 [Abstract] [Full Text] [Related]
11. Activation of the coagulation cascade in patients with leptospirosis. Chierakul W, Tientadakul P, Suputtamongkol Y, Wuthiekanun V, Phimda K, Limpaiboon R, Opartkiattikul N, White NJ, Peacock SJ, Day NP. Clin Infect Dis; 2008 Jan 15; 46(2):254-60. PubMed ID: 18171258 [Abstract] [Full Text] [Related]
12. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers]. Koike K, Fujimaki M. Nihon Rinsho; 1993 Jan 15; 51(1):37-42. PubMed ID: 8433526 [Abstract] [Full Text] [Related]
13. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation. Matsuo T, Matsuo M, Sugimoto T, Wanaka K. Pathophysiol Haemost Thromb; 2007 Jan 15; 36(6):305-10. PubMed ID: 20224256 [Abstract] [Full Text] [Related]
14. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation. Okajima K, Uchiba M, Murakami K, Okabe H, Takatsuki K. Am J Hematol; 1996 Mar 15; 51(3):186-91. PubMed ID: 8619398 [Abstract] [Full Text] [Related]
15. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, Gomi K, Sugihara T, Kiyota T, Yamamoto S. Thromb Haemost; 1994 Apr 15; 71(4):452-5. PubMed ID: 8052962 [Abstract] [Full Text] [Related]
16. [Molecular marker for detecting hypercoagulable state]. Magari Y, Mizunaga S, Ito M, Shibata T, Ito H. Rinsho Byori; 1994 Jan 15; 42(1):22-33. PubMed ID: 8107279 [Abstract] [Full Text] [Related]
17. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock. Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, Zakynthinos SG. Intensive Care Med; 2001 Dec 15; 27(12):1853-9. PubMed ID: 11797019 [Abstract] [Full Text] [Related]
18. [Coagulation tests in septic surgical patients]. Oberhofer D, Kucisec-Tepes N, Skok J, Vucić N, Cala K. Acta Med Croatica; 2004 Dec 15; 58(5):389-94. PubMed ID: 15756805 [Abstract] [Full Text] [Related]
19. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation. Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Deguchi H, Mori Y, Kaneko T, Deguchi K, Fujii J, Shiku H. Am J Hematol; 1996 Apr 15; 51(4):255-60. PubMed ID: 8602623 [Abstract] [Full Text] [Related]
20. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Matsuda T. Blood Coagul Fibrinolysis; 1994 Oct 15; 5(5):829-32. PubMed ID: 7865691 [Abstract] [Full Text] [Related] Page: [Next] [New Search]